{
  "id": 12969140,
  "title": "Neuraxis CRO Carrico buys $1,587 in common stock",
  "url": "https://urgent.news/2026/10/08/neuraxis-cro-carrico-buys-1-587-in-common-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-08T22:16:02.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/neuraxis-cro-carrico-buys-1587-in-common-stock-93CH-4939915"
  },
  "original_language": "en",
  "account": "Neuraxis CRO Carrico purchases 328 shares of company stock on Oct 8, 2026\n\nNeuraxis CRO and CEO Thomas Joseph Carrico recently bought 328 shares of Neuraxis common stock for a total of $1,587 on October 8, 2026. The shares were purchased at a price of $4.84 per share, representing a 40% increase from the purchase price. This brings Carrico's direct ownership of Neuraxis common stock to 199,673 shares. The acquisition comes amid positive market sentiment, with NRXS shares currently trading at $6.77, up 116% over the past year. InvestingPro suggests the stock has strong potential, noting it is slightly undervalued based on its Fair Value analysis. Neuraxis also reported strong financial results for Q2 2026, with revenue increasing 116% year over year to $1.928 million. However, the company reported a loss per share of $0.19, exceeding analyst estimates. Despite this, Neuraxis sees growth in its gross margins. Investors are watching these developments as they gauge the company's future performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}